Literature DB >> 8342535

A simple, practical model for reducing alloimmunization in patients with sickle cell disease.

S D Sosler1, B J Jilly, C Saporito, M Koshy.   

Abstract

Patients with sickle cell disease (SCD) form immune alloantibodies more frequently than other transfused populations because red cells (RBCs) from white donors (with a higher incidence of certain Rh, Duffy, Kell, and Kidd blood group antigens) are transfused to black patients often lacking these antigens. We propose a model to reduce alloimmunization in patients with SCD by providing them with blood from only black random donors. Rationale is shown by examining calculations based on the phenotype E-, C-, Fy(a-), K-, and Jk(b-). There is a 7% probability that this phenotype belongs to a white donor, while there is a 93% probability that this phenotype belongs to a black donor. The probability of selecting blood from a black donor identical with the above phenotype for black recipients from an all black population and from a typical urban blood inventory population (90% white, 10% black) is 1/4 and 1/33, respectively. Therefore, an 8-fold greater chance of selecting antigen non-identical blood occurs if blood is obtained from a typical urban donor population as compared to a black population. Based on these calculations, alloimmunization can be reduced prospectively in patients with SCD by meeting their transfusion requirements with blood selected from random black blood donors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342535     DOI: 10.1002/ajh.2830430206

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease.

Authors:  Marion E Reid; Christine Halter Hipsky; Kim Hue-Roye; Carolyn Hoppe
Journal:  Blood Cells Mol Dis       Date:  2013-12-02       Impact factor: 3.039

2.  Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients.

Authors:  Daiane Cobianchi da Costa; Jordão Pellegrino; Gláucia Andréia Soares Guelsin; Karina Antero Rosa Ribeiro; Simone Cristina Olenscki Gilli; Lilian Castilho
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.